Targeting Activator Protein-1 Transcription Factor Subunit FOSL1-Mediated Cuproptosis Sensitizes Radioresistant Non-Small Cell Lung Cancer
- 3 August 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (32) , 22804-22822
Abstract
Radiotherapy plays a pivotal role in the management of nonsmall-cell lung cancer (NSCLC), particularly for patients who are not candidates for surgical intervention. Despite its significance, the issue of radioresistance remains a substantial challenge in the treatment of the NSCLC. Therefore, it is crucial to uncover new targets to enhance radiotherapy and investigate the mechanisms underlying radioresistance. Cuproptosis, as an emerging form of cell death dependent on intracellular copper (Cu) ions, remains unclear in its role in radioresistant NSCLCs. This study investigates the development of radioresistant NSCLC models, focusing on the role of the FOS-like antigen 1 (FOSL1) as a significant factor in mediating radioresistance. The FOSL1 gene is downregulated in radioresistant cells. Overexpression of FOSL1 induces mitochondrial damage and dysfunction, causing cuproptosis in radioresistant cells. To tackle the challenge of radioresistance in NSCLC, we propose an innovative nanostrategy focused on cuproptosis, aiming to enhance the efficacy of radiotherapy specifically in radioresistant NSCLC. This intervention could significantly enhance an increase in intracellular Cu2+ concentration and glutathione depletion while also increasing irradiation (IR)-induced oxidative stress and mitochondrial damage. The resulting mitochondrial dysfunction leads to tricarboxylic acid cycle disruption and Fe–S cluster protein destabilization. These cumulative effects ultimately induced cuproptosis and enhanced the response of radioresistant NSCLC cells to IR. Our findings highlight the potential of combining cuproptosis targeting with nanotechnology to enhance the efficacy of radiotherapy, presenting a promising strategy to address radioresistance in clinical contexts.Keywords
Funding Information
- Construction Project for the Graded Diagnosis and Treatment of Complex Gynecological Tumors and a Training Base for Precision Radiotherapy (none)
- Construction Project of the Clinical Medical Research Center in Jilin Province (no)
- National Natural Science Foundation of China (52371254)
- National Natural Science Foundation of China (82404194)
This publication has 36 references indexed in Scilit:
- GCSH promotes colorectal cancer progression by inhibiting Cuproptosis through the PI3K/AKT-FDX1 axisFunctional & Integrative Genomics, 2026
- Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistanceCancer Cell, 2025
- Pyruvate metabolism enzyme DLAT promotes tumorigenesis by suppressing leucine catabolismCell Metabolism, 2025
- Copper homeostasis and cuproptosis in radiation-induced injuryBiomedicine & Pharmacotherapy, 2024
- Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, “futile” fatty acid cycling, and FADH2 oxidationGeroScience, 2024
- Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicityJournal of Cancer Research and Clinical Oncology, 2023
- NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancerApoptosis, 2022
- Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agentLife Sciences, 2022
- Photothermal conversion-coordinated Fenton-like and photocatalytic reactions of Cu2-xSe-Au Janus nanoparticles for tri-combination antitumor therapyBiomaterials, 2020
- Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpointFree Radical Biology and Medicine, 2012